(Q73850903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

M T Fields

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Eisbruch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Orfali

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M A Davis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A T Pu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T S Lawrence

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

785-791

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Radiosensitizing nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Acute reactions of the lip mucosa of mice to fractionated irradiations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

An in vivo model for squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrop

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900447-8

7 January 2021

10.1016/S0360-3016(00)00447-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837965%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference